Cargando…

Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

OBJECTIVE: The study was to assess the knowledge of warfarin in patients using the validated anticoagulation knowledge assessment questionnaire and to evaluate the predictors of the level of knowledge among outpatients receiving warfarin at the Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiop...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabeyu, Abdella Birhan, Ayanaw, Meaza Adugna, Haile, Kaleab Taye, Kifle, Zemene Demelash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666346/
https://www.ncbi.nlm.nih.gov/pubmed/34917918
http://dx.doi.org/10.1016/j.metop.2021.100155
_version_ 1784614188915621888
author Yabeyu, Abdella Birhan
Ayanaw, Meaza Adugna
Haile, Kaleab Taye
Kifle, Zemene Demelash
author_facet Yabeyu, Abdella Birhan
Ayanaw, Meaza Adugna
Haile, Kaleab Taye
Kifle, Zemene Demelash
author_sort Yabeyu, Abdella Birhan
collection PubMed
description OBJECTIVE: The study was to assess the knowledge of warfarin in patients using the validated anticoagulation knowledge assessment questionnaire and to evaluate the predictors of the level of knowledge among outpatients receiving warfarin at the Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. METHODS: It was a prospective cross-sectional study carried out from October 2019–January 2020. During the study period a total 401 of them were included in the study. Anticoagulation Knowledge Assessment questionnaire has 29 question items, a single patient should answer at least 21 of the question to be considered as knowledgeable about his/her medication. The data was exported into SPSS version 25 and a one way ANOVA and post hoc were conducted. RESULTS: The mean age of the study participants were 36 years old (SD ± 11.83), which was ranges from 18 to 82 and majority of the participants were females (69.6%). Almost in one-third of the participants (35.7%), the reasons for warfarin therapy were Chronic Rheumatic Valvular Heart Disease. The overall AKA mean ± SD score of the respondents was 7.4 (±2.6) that ranges from 2 to 22. From those only (4.2%) of the study participants had succeeds the passing score. Educational level and the duration of warfarin therapy were independent predictors towards patient’s warfarin knowledge. CONCLUSION: The overall patient’s knowledge about warfarin treatment was poor when it was compared to most other studies. The longer duration of warfarin therapy and advanced educational level showed favored relationship towards better warfarin knowledge of the study participants.
format Online
Article
Text
id pubmed-8666346
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86663462021-12-15 Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia Yabeyu, Abdella Birhan Ayanaw, Meaza Adugna Haile, Kaleab Taye Kifle, Zemene Demelash Metabol Open Original Research Paper OBJECTIVE: The study was to assess the knowledge of warfarin in patients using the validated anticoagulation knowledge assessment questionnaire and to evaluate the predictors of the level of knowledge among outpatients receiving warfarin at the Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. METHODS: It was a prospective cross-sectional study carried out from October 2019–January 2020. During the study period a total 401 of them were included in the study. Anticoagulation Knowledge Assessment questionnaire has 29 question items, a single patient should answer at least 21 of the question to be considered as knowledgeable about his/her medication. The data was exported into SPSS version 25 and a one way ANOVA and post hoc were conducted. RESULTS: The mean age of the study participants were 36 years old (SD ± 11.83), which was ranges from 18 to 82 and majority of the participants were females (69.6%). Almost in one-third of the participants (35.7%), the reasons for warfarin therapy were Chronic Rheumatic Valvular Heart Disease. The overall AKA mean ± SD score of the respondents was 7.4 (±2.6) that ranges from 2 to 22. From those only (4.2%) of the study participants had succeeds the passing score. Educational level and the duration of warfarin therapy were independent predictors towards patient’s warfarin knowledge. CONCLUSION: The overall patient’s knowledge about warfarin treatment was poor when it was compared to most other studies. The longer duration of warfarin therapy and advanced educational level showed favored relationship towards better warfarin knowledge of the study participants. Elsevier 2021-12-07 /pmc/articles/PMC8666346/ /pubmed/34917918 http://dx.doi.org/10.1016/j.metop.2021.100155 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Paper
Yabeyu, Abdella Birhan
Ayanaw, Meaza Adugna
Haile, Kaleab Taye
Kifle, Zemene Demelash
Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
title Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
title_full Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
title_fullStr Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
title_full_unstemmed Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
title_short Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
title_sort evaluation of patients' knowledge of warfarin at tikur anbessa specialized hospital, addis ababa, ethiopia
topic Original Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666346/
https://www.ncbi.nlm.nih.gov/pubmed/34917918
http://dx.doi.org/10.1016/j.metop.2021.100155
work_keys_str_mv AT yabeyuabdellabirhan evaluationofpatientsknowledgeofwarfarinattikuranbessaspecializedhospitaladdisababaethiopia
AT ayanawmeazaadugna evaluationofpatientsknowledgeofwarfarinattikuranbessaspecializedhospitaladdisababaethiopia
AT hailekaleabtaye evaluationofpatientsknowledgeofwarfarinattikuranbessaspecializedhospitaladdisababaethiopia
AT kiflezemenedemelash evaluationofpatientsknowledgeofwarfarinattikuranbessaspecializedhospitaladdisababaethiopia